ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Form 6-K — Oct 15, 2026
Ascentage Pharma announced that on October 15, 2026 its Trustee purchased 200,000 existing shares on-market for approximately HK$5.78 million (about HK$28.89 per share) to satisfy RSUs under the 2022 RSU Scheme. The purchase represents roughly 0.05% of issued shares, bringing total trustee-held shares for the scheme to 2,915,000.
Key figures
- Gross Proceeds
- HK$5,778,916
- Offering Price
- HK$28.89
- Shares Offered
- 200000
- Purchase Date
- October 15, 2026
- Purchased Shares Percent Of Issued
- 0.05%
- Total Shares Held By Trustee After Purchase
- 2915000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.